Research

We support and conduct high-quality psychedelic research

The MIND Foundation’s research projects are geared towards evidence-based practice and high-quality science. For many of these projects, we are working together with universities in and outside of Germany and in collaboration with our Scientific Advisory Board. We invite you to explore our current projects, which are listed below.

COOPERATION PARTNER IN PSILOCYBIN DEPRESSION STUDY

Principal investigator Prof. Dr. med. Gerhard Gründer has received the final approval for a psilocybin depression study (EPIsoDE) at the Central Institute of Mental Health Mannheim and the Charité Universitätsmedizin Berlin.  The MIND Foundation is a cooperation partner in the EPIsoDE study.

Studies & Surveys

Find out more about participation in studies and online surveys. You will find studies & surveys that are directly supported by MIND as well as those conducted by other universities and institutes, which are featured here.

Resources

Psychedelic research has implications for a wide range of people and professions. Check out some useful resources for newcomers and those looking to deepen their understanding of the subject.

UNIMIND

uniMIND sets up academic journal clubs across the world to discuss psychedelic research. Students as well as senior academics of any level and any background are invited to engage in critical discourse on altered states of consciousness and psychedelics.

MIND Awards

In recognition of outstanding contributions to the psychedelic research and therapy field, we award young and established academics prizes of various kinds. Usually at the INSIGHT conference.

Research Fellowships

The MIND Foundation’s Research Fellowship program 2020 provides two fellowships for doctoral students.

Interview
Drug Science
Predicting the Temporal Dynamics of the Psychedelic Experience

The notion that the psychedelic experience consists of three phases, namely come-up, peak, and come-down, is now backed by neuroscience. And PET scans can predict the unfolding of these phases.

Dr. Dea Siggaard StenbækDr. Lukas Basedow
•
martie 26, 2021
Perspective
Clinical Psychology
Insights Into the Inaugural Year of APT — a New Training for Becoming a Psychedelic Therapist

MIND Foundation’s Augmented Psychotherapy Training (APT) is a 2-year professional development program that teaches the skills needed for psychedelic therapy.

Steph Lee, M.A.
•
octombrie 12, 2022
Essay
Drug Science
The Synthetic Toad – How To Investigate 5-MeO-DMT in the Lab

The psychedelic drug 5-MeO-DMT is found naturally in the venom of the Sonoran Desert toad. Promising findings from field and early clinical research suggest that the substance may have therapeutic value as a rapid antidepressant.

Johannes Reckweg, M.Sc.Dr. Lukas Basedow
•
iulie 28, 2022
Essay
Consciousness Research
Merging Biology and Psychotherapy Within Psychiatry: An Interview with Collin Reiff, MD

Psychiatry has fluctuated between biology and psychotherapy throughout its history. Where are we now, and what impact might psychedelics have on the field?

Collin Reiff, MDSaga Briggs
•
mai 13, 2022